Core Viewpoint - DOMA Perpetual Capital Management LLC urges InMode Ltd.'s Board to resume and accelerate stock buybacks and replace CEO Moshe Mizrahy due to concerns over capital allocation strategy and declining stock performance [1][2][3]. Capital Allocation Strategy - The letter emphasizes the need for the Board to act on behalf of shareholders by resuming the share repurchase program and returning cash to shareholders, as the current cash on the balance sheet is not generating earnings [3][4]. - InMode's stock price is viewed as undervalued, with approximately 60% of its market cap in cash, and the company maintains no debt while generating free cash flow [4][7]. CEO Performance and Leadership Concerns - CEO Moshe Mizrahy's management style is criticized as reckless and antagonistic, contributing to the company's underperformance and negative public perception [2][5]. - The letter highlights that Mizrahy has consistently lowered guidance and made poor management decisions, such as firing the US Head of Sales before a critical quarter [5][6]. Financial Performance and Valuation - As of May 7, 2025, InMode's market capitalization, excluding cash, is approximately $375 million, which does not reflect the company's strong business fundamentals, including gross margins near 80% [7][8]. - The letter argues that the current valuation is disconnected from the reality of InMode's business, which includes valuable assets like inventory, global distribution, and unique intellectual property [7][8].

SANTA ANA, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ:TTMI) today announced that its Board of Directors authorized a new share repurchase program allowing the Company to repurchase its outstanding common stock with an aggregate market value of up to $100 million from time to time through May 7, 2027. The Company’s previous two-year repurchase program expired on May 3, 2025. “Given the company’s solid cash flow generation and strong balance sheet, we believe repurchasing shares i ...

Turtle Beach (HEAR) Q1 2025 Earnings Call May 08, 2025 05:00 PM ET Company Participants Jacques Cornet - PartnerCris Keirn - CEOMark Weinswig - CFO Conference Call Participants Anthony Stoss - AnalystSean McGowan - MD & Senior Research AnalystMartin Yang - Senior AnalystNone - Analyst Operator and welcome to Turtle Beach Q1 twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. As a remin ...

EverCommerce (EVCM) Q1 2025 Earnings Call May 08, 2025 05:00 PM ET Company Participants Bradley Korch - Senior VP & Head of Investor RelationsEric Remer - Founder, Chairman & CEORyan Siurek - Chief Financial OfficerWilliam McNamara - Equity Research Senior AssociateMatt Feierstein - PresidentEvan Berlin - CEO of EverhealthJosh McCarter - CEO of EverProAaron Kimson - Vice President Conference Call Participants None - Analyst Operator Thank you for standing by and welcome to EverCommerce's First Quarter twent ...

Financial Data and Key Metrics Changes - In Q1 2025, GAAP revenue increased by 3.2% year over year, while on a pro forma basis, revenue grew by 7.4% year over year [7][17] - Adjusted EBITDA was $44.9 million, representing a margin of 31.6%, with a year-over-year margin expansion of nearly 360 basis points [8][18] - Total payment volume (TPV) for Q1 was approximately $12.7 billion, reflecting nearly 9% year-over-year growth [16] Business Line Data and Key Metrics Changes - Subscription and transaction revenue grew by 8.1% year over year, with adjusted gross profit of $111.1 million, resulting in an adjusted gross margin of 78.1% [10][19] - EverPro and EverHealth verticals accounted for 95% of consolidated revenue, with significant growth opportunities identified in payment integrations and additional product offerings [9][27] Market Data and Key Metrics Changes - The company reported a net revenue retention (NRR) of 97% over the trailing twelve months, indicating strong customer loyalty and revenue stability [15] - Approximately 240,000 customers were enabled for more than one solution, reflecting a 20% year-over-year growth [13] Company Strategy and Development Direction - The company is focusing on integrating AI capabilities into its products to enhance innovation and operational efficiency [11] - Strategic investments are being made in payment platforms to drive adoption and revenue growth, with a focus on optimizing go-to-market strategies [16][36] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of their end markets, noting no significant degradation in key metrics despite macroeconomic volatility [31][33] - Guidance for Q2 2025 remains unchanged, with expected total revenue between $144.5 million and $147.5 million, and adjusted EBITDA between $39.5 million and $41.5 million [22] Other Important Information - The Board of Directors approved a $50 million increase to the share repurchase program, extending the authorization to year-end 2026 [8][21] - The company generated significant free cash flow, with cash flow from operations for the quarter at $30.7 million, more than double the previous year [20] Q&A Session Summary Question: How has prioritizing payment attachment at the point of sale impacted sales teams? - Management noted positive results in Q1, with increased payment attachment seen with new customers, and emphasized ongoing efforts to integrate payment selling into SaaS workflows [24][26] Question: What are the biggest upsell opportunities within EverPro, EverHealth, and EverWell? - Management highlighted payments as the largest growth opportunity, along with additional product integrations to enhance customer experience and value [27][28] Question: Any changes in pipeline activity or net expansion metrics due to macroeconomic factors? - Management reported no degradation in key metrics and stated that business operations remain stable despite macroeconomic concerns [31][32] Question: Is there potential tariff exposure on the EverPro side of the business? - Management indicated that most of the EverPro business is break-fix, suggesting limited direct exposure to tariffs, although some supply costs may be affected [40] Question: Any surprises or areas of improvement identified in the EverPro business? - Management expressed optimism about growth opportunities in payments and cross-selling other products, emphasizing the potential for significant improvements [42]

–Net Revenue of $63.9 million, up 14% compared to prior year––Gross Margin improved to 36.6%, an increase of approximately 470 basis points compared to prior year––Net Loss of $(0.7) million compared to Net Income of $0.2 million in prior year––Adjusted EBITDA of $4.1 million, up from $1.4 million in prior year––Generated $40.5 million in cash flow from operations, the highest level since 2019––Authorized a new $75 million stock repurchase program– SAN DIEGO, May 08, 2025 (GLOBE NEWSWIRE) -- Turtle Beach Co ...

Flutter Entertainment plc announces launch of third tranche of share repurchase program DUBLIN and TORONTO and NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Flutter Entertainment plc (“Flutter”) (NYSE:FLUT; LSE:FLTR), the world's leading online sports betting and iGaming operator, announces that it has entered into non-discretionary arrangements with Davy Securities Unlimited Company to repurchase ordinary shares on Flutter’s behalf for an aggregate maximum consideration of up to $225 million on the New York S ...

Core Insights - ADMA Biologics reported a strong financial performance in Q1 2025, with total revenue of $114.8 million, representing a 40% year-over-year increase, and adjusted total revenue of $118.6 million, indicating approximately 45% growth when excluding one-time product withdrawals [1][9] - The company achieved a GAAP net income of $26.9 million, a 51% increase year-over-year, and an adjusted net income of $33.3 million, reflecting an 87% year-over-year growth [1][11] - Adjusted EBITDA for the quarter was $47.9 million, marking an 81% increase compared to the same period last year [1][12] Financial Performance - Total cash and receivables grew to approximately $171 million, providing a strong liquidity position [1][3] - The gross profit for Q1 2025 was $61.1 million, translating to a gross margin of 53.2%, up from 47.8% in Q1 2024 [10] - The company has increased its total revenue guidance for FY 2025 to more than $500 million and for FY 2026 to more than $625 million [1][7] Strategic Developments - The FDA approved a yield enhancement production process, expected to increase production output by 20% from the same starting plasma volume, which is anticipated to support revenue growth and margin expansion [1][3] - ADMA has authorized a $500 million share repurchase program, representing approximately 8% of its current market capitalization, aimed at enhancing stockholder value [1][8] - A debt reorganization has reduced ADMA's cost of debt capital by 1.1%, further strengthening its financial position [1][3] Market Position and Outlook - The company expects total annual revenues to exceed $1.1 billion by 2030, with significant earnings growth anticipated from current margin levels [2][7] - ADMA's U.S.-based manufacturing and supply chain provide insulation from geopolitical and global trade challenges, positioning the company favorably against multinational competitors [3][7] - The demand for ASCENIV, one of ADMA's key products, continues to trend towards record highs, with expectations for increased market penetration and new patient starts [4][7]

Financial Data and Key Metrics Changes - The company reported consolidated revenue growth of 11% year over year, or 21% on a constant currency basis [6][18] - Gross profit margin increased by 217 basis points to 29.3%, and adjusted EBITDA margins improved nearly 90 basis points to 4.8% [6][20] - Adjusted EBITDA for the trailing twelve months reached $1.5 billion, with free cash flow exceeding $1 billion [6][24] - Operating income grew to $154 million, a year-over-year increase of nearly 300% [22] - Net income attributable to stockholders was $107 million, resulting in diluted earnings per share of $0.06 [22] Business Line Data and Key Metrics Changes - Product Commerce segment revenues grew by 6% year over year, or 16% in constant currency, with active customers increasing by 9% [19] - Developing Offerings segment revenues surged by 67% year over year, or 78% in constant currency, driven by strong customer engagement in Eats and Taiwan [19][20] - Product Commerce gross profit was $2.2 billion, with a gross profit margin of 31.3%, reflecting a margin improvement of over 300 basis points year over year [20] Market Data and Key Metrics Changes - The company experienced strong momentum in Taiwan, with selection expanding by nearly 500% this quarter [12][43] - The Eats segment continued to sustain momentum, with strong customer enthusiasm and growth in both revenue and margin [15][38] Company Strategy and Development Direction - The company is focused on expanding selection, lowering prices, and enhancing delivery experiences to drive sustained growth [7][11] - Significant investments are being made in technology, innovation, automation, and robotics to improve operations and customer experience [10][11] - The company is optimistic about the potential in Taiwan, aiming to replicate the success seen in Korea [12][43] Management's Comments on Operating Environment and Future Outlook - Management noted that there has not been a meaningful impact from recent global events on the business, and they will continue to monitor the macroeconomic environment closely [17][29] - The company expects a full-year constant currency consolidated growth rate of about 20% [29][35] - Management remains confident in the long-term trajectory of investments in Taiwan and other developing offerings [43][54] Other Important Information - The board approved a $1 billion share repurchase program to act opportunistically in the market [26][30] - The effective income tax rate was reported at 47%, influenced by losses in early-stage operations in Taiwan [25] Q&A Session Summary Question: Impact of macro and tariff on business and user behavior - Management indicated limited impact from macro conditions and tariffs, with no significant changes in consumer behavior observed [29] Question: Details on the stock repurchase plan and capital allocation strategy - The share repurchase program is designed to generate meaningful returns for shareholders, with no fixed term for execution [30][31] Question: Revenue growth guidance and product commerce outlook - Management confirmed confidence in achieving the 20% revenue growth target despite current macro conditions [35] Question: Developing offerings loss and margin trends in Eats and Taiwan - Management acknowledged increased losses in developing offerings but highlighted strong growth and engagement in Eats and Taiwan [38][43] Question: Timeline for the share repurchase and user changes in Taiwan - There is no fixed timeline for the $1 billion repurchase, and management is optimistic about growth in Taiwan, expecting more changes in the coming quarters [41][43] Question: Growth for FLC and technology investment cycle - FLC is growing at a high multiple of the overall business, and the company is in the midst of a technology investment cycle that is expected to yield long-term benefits [51][55] Question: Impact of Chinese competitors on the market - Management emphasized a focus on providing the best customer experience and selection, regardless of competitor actions [54]

Great Lakes Dredge & Dock (GLDD) Q1 2025 Earnings Call May 06, 2025 10:00 AM ET Speaker0 Good day, and thank you for standing by. Welcome to the Q1 twenty twenty five Great Lakes Dredge and Dock Corp Earnings Conference Call. At this time, all participants are in listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising that your hand is r ...